Collagen vascular grafts recalled over unapproved bovine raw material supplier
LeMaitre Vascular is recalling 28 Artegraft Collagen Vascular Grafts because the bovine carotid arteries used to make them came from a supplier not reviewed and approved by the appropriate regulatory authority.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record describes a regulatory approval gap in the raw material supply chain rather than an identified product defect or reported harm.
Plain-English summary
Artegraft Collagen Vascular Grafts, model numbers AG 616, AG 630, AG 636, AG 640, AG 645, AG 715, AG 730, AG 735, AG 740, AG 745, AG 750, AG 830, AG 840, AG 1015 and AG 1030, are being recalled.
The bovine carotid arteries used to produce the affected lots were sourced using raw material from a supplier that had not been reviewed and approved by the appropriate regulatory authority.
The recall covers 28 units, distributed in California, Connecticut, Florida, Georgia, Illinois, Massachusetts, Mississippi, North Carolina, North Dakota, New Jersey, New York, Oklahoma, Pennsylvania, Tennessee, Texas, Virginia and Washington. The FDA has classified the action as Class II.
The enforcement record describes a supplier approval gap rather than a defect found in the grafts themselves, and reports no injuries. Facilities holding affected model and lot numbers should follow LeMaitre's instructions.
The recalled product
- Product
- Artegraft Collagen Vascular Grafts Model Numbers: (1) AG 616, (2) AG 630, (3) AG 636, (4) AG 640, (5) AG 645, (6) AG 715, (7) AG 730, (8) AG 735, (9) AG 740, (10) AG 745, (11) AG 750, (12) AG 830, (13) AG 840, (14) AG 1015, (15) AG 1030;
- Manufacturer
- LeMaitre Vascular, Inc.
- Category
- Medical Device — Vascular graft
- Affected units
- 28
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Model Numbers: (1) AG 616
- (2) AG 630
- (3) AG 636
- (4) AG 640
- (5) AG 645
- (6) AG 715
- (7) AG 730
- (8) AG 735
- (9) AG 740
- (10) AG 745
- (11) AG 750
- (12) AG 830
- (13) AG 840
- (14) AG 1015
- (15) AG 1030
- UDI-DIs: (1) 00316837000213
- (2) 00316837000220
- (3) 00316837000237
- (4) 00316837000244
- (5) 00316837000251
Distribution
Related recalls
Same manufacturer · LeMaitre Vascular, Inc.
See all →- ModerateLeMaitre TufTex Over-the-Wire Embolectomy Catheter Recalled for Balloon Failure
FDA (Devices) · 2026-10-14
- ModerateArtegraft vascular graft recalled over incorrect lot outer packaging labeling
FDA (Devices) · 2026-03-25
- ModerateCollagen vascular graft recalled after being packed in wrong size packaging
FDA (Devices) · 2025-10-29
- ModerateCollagen vascular grafts recalled over incorrect labels missing CE and UKCA marks
FDA (Devices) · 2025-10-15
- SevereTufTex Over-the-Wire Embolectomy Catheter incomplete sterile barrier
FDA (Devices) · 2025-05-21
Same hazard · unapproved supplier
See all →- HighPrescription Drug Recall: Ramipril Capsules from Unapproved Supplier
FDA (Drugs) · 2024-11-27
- HighRamipril Capsule Medication Recalled Over Unapproved Vendor Manufacturing Deviations
FDA (Drugs) · 2024-11-27
Similar recalls
- ModerateCollagen vascular grafts recalled over incorrect labels missing CE and UKCA marks
FDA (Devices) · 2025-10-15
- ModerateCollagen vascular graft recalled after being packed in wrong size packaging
FDA (Devices) · 2025-10-29
- CriticalLeMaitre Vascular Recalls AlboGraft Vascular Grafts Due to Surface Leaking
FDA (Devices) · 2013-07-31
- CriticalLeMaitre AlboGraft Vascular Grafts Recalled for Surface Leakage
FDA (Devices) · 2013-07-31
- CriticalLeMaitre Recalls AlboGraft Vascular Grafts Due to Surface Bleeding
FDA (Devices) · 2013-07-31
- SevereLeMaitre Recalls AlboGraft Vascular Grafts Due to Blood Leaking
FDA (Devices) · 2013-07-31